Morphosys Research Site

Budapest H-1122

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-cell Lymphoma, Non-Hodgkin Lymphoma

Studies at this site

• Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients — Running, not enrolling
• Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin's Lymphoma (NHL) — Completed